2015年前沿科技国际孵化器引进北京经济技术开发区的项目P7：首次举办北京生物技术和新医药产业促进中心承办的“第十九届北京国际生物医药产业发展论坛”的前导分会场，“第一届信息菌素类药物研究与应用研讨会”，吸引了来自世界各地研究如何应对抗生素耐药难题的顶尖科学家、产业家的积极参与，他们的目标只有一个，论证信息菌素是不是人类应对细菌耐药——对人类健康严重威胁的一个重大突破，纵论这一成果将会给抗生素乃至医药产业带来哪些历史性的变化。Frontier Technologies International Development, Ltd. Portfolio 7 entering Beijing Economic-technological Development Area (BDA) in 2015: As the foreword meeting of the 19th Beijing International Healthcare Industry Forum, the First International Workshop on the Pheromonicin Drug Development Platform has attracted world top scientists and industrialists who are researching on how to fight problems of antibiotic-resistance. In this Workshop, participants’ sole mission is to validate if Pheromonicin is a major breakthrough of people versus drug-resistant bacteria, which is a serious threat to the healthy mankind. Let’s discuss how this achievement will change antibiotic and further the medicine industry with a historical impact under making.
出席此次研讨会的有：中国疾病预防控制中心副主任、中国科学院微生物所副所长、中国科学院院士高福；中国疾病预防控制中心徐建国院士；北京协和医学院李辉教授；英国生物制药业权威顾问、诺丁汉大学的理查德·詹姆斯教授；美国科学协进会戈登会议（药物耐受专题）发起人玛格丽特·莱利教授；美国牛津生物科学投资集团负责人、戈登会议（药物耐受）2016分会主席曼维尔·纳维亚研究员；文特尔（诺贝尔奖得主、美国基因组计划创始人）研究所所长凯伦·纳尔逊博士；PnuVAX公司（世界级抗体和疫苗制药公司）总裁唐纳德·盖尔逊先生；美国史密斯学院罗伯特·多尔特教授等60余位学者。他们站在不同的学术研究和制药工业高度，对信息菌素创始人丘小庆教授的开拓性研究工作给予了高度的评价——“意义深远，世纪挑战、世界震动”。Participants of this Workshop included 60+ scientists such as: Gao Fu, a member of Chinese Academy of Sciences, deputy director of China CDC, deputy director of Microbiology Institute under Chinese Academy of Sciences; Xu Jianguo,a member of Chinese Academy of Sciences from China CDC; Prof. Richard James of Nottingham University, an influential scientific advisor of UK Pharmaceutical Industry; Prof. Margaret Riley who is Gordon Research Conference Drug-resistance Meeting’s initiator and Chairperson; Dr. Manuel Navia, Oxford Science and Investment Group’s executive and Gordon Drug-resistance Meeting’s Chairman of next term (2016); Dr. Karen Nelson, director of J. Craig Venter Institute (founded by the influential Nobel Laureate and US Gene Group Planner and Founder); Donald Gerson, CEO of a world top antibiotic and vaccine manufacturing company PnuVAX; Prof. Robert Dorit from Smith College; etc. They hold various views from academic research and pharmaceutical industrial angles, respectively appraised highly about Dr. Xiaoqing Qiu’s creative research works, as “with long suspending meaning, a new century challenge, and impacting the world”.
“信息菌素类药物的研究思路富有创新性，这次会议很有意义，虽不能至，心向往之，祝会议圆满成功！”国家“重大新药创制”科技重大专项技术副总师、上海市科协主席陈凯先院士从上海发来贺信给丘小庆教授，赞赏他的创新精神，并表达了对于信息菌素未来发展所寄托的希望。“The research path about Pheromonicin platform drug hosts a wealth of innovations. This Workshop is so important, though I cannot participate, but my whole heart is go for it now. Wish the meeting success!” This is from the congratulation letter, by Dr. Chen Kaixian, a member of Chinese Academy of Sciences, State Major New Drug Creation and Manufacture Program’s deputy Technical General, Chairman of Shanghai Science Society. He appreciated Dr. Qiu’s creative spirit, and expressed his hope and expectation for Pheromonicin’s development.
详情见《科技日报》2015年10月22日第9版。